Streptococcus pneumoniae 356 moxifloxacin (MFLX), garenoxacin (GRNX) sitafloxacin
|
|
- Maximillian Howard
- 5 years ago
- Views:
Transcription
1 ) 1, 2) 1, 2) 1) 1) 2) 1) 1) 1) 1) 1) 1, 2) 1) 2) Streptococcus pneumoniae 356 moxifloxacin (MFLX), garenoxacin (GRNX) sitafloxacin (STFX), DX619 S. pneumoniae S. pneumoniae 60 penicillin G (PCG) 264 (74.2 ) clarithromycin (CAM) telithromycin (TEL) MIC 2 mg/ml 9 (2.5 ) MIC 90 (mg/ml) DX619 ( 0.031), GRNX (0.063), STFX (0.063), tosufloxacin (TFLX) (0.25), MFLX (0.25), gatifloxacin (GFLX) (0.5), levofloxacin (LVFX) (1), ciprofloxacin (CPFX) (2), pazufloxacin (PZFX) (2) LVFX, TEL 2 mg/ml 12 9 S. pneumoniae 1. (Streptococcus pneumoniae) S. pneumoniae S. pneumoniae , 2) S. pneumoniae ) Haemophilus influenzae ( ) TEL: penicillin G: PCG (penicillin-resistant S. pneumoniae; PRSP, penicillin-intermediate S. pneumoniae; PISP) S. pneumoniae PCG S. pneumoniae PCG 4) PCG minocycline (MINO) (multi-drug resistant S. pneumoniae; MDRSP) 5) S. pneumoniae Vol. 19 No
2 22 levofloxacin (LVFX), tosufloxacin (TFLX), sparfloxacin (SPFX), gatifloxacin (GFLX) moxifloxacin (MFLX), garenoxacin (GRNX) 2 S. pneumoniae sitafloxacin (STFX) DX619 S. pneumoniae 356 (PFGE) PFGE LVFX, TEL 2 mg/ml PFGE PFGE 10 Todd Hewitt broth 35 SmaI CHEF Mapper (Bio-Rad) Fingerprinting II (Bio-Rad) similarity 2. S. pneumoniae S. pneumoniae 356 a VITEK2 S. pneumoniae Clinical Laboratory Standards Institute (CLSI) (MIC) 6) PCG, clarithromycin CAM telithromycin TEL LVFX TFLX GFLX ciprofloxacin CPFX pazufloxacin PZFX MFLX GRNX STFX DX S. pneumoniae 356 MIC 90 (mg/ml) DX619 ( 0.031), GRNX (0.063), STFX (0.063), TFLX (0.25), MFLX (0.25), GFLX (0.5), LVFX (1), CPFX (2), PZFX (2) PCG, CAM 22 Vol. 19 No
3 23 3. PCG CAM CPFX 1. LVFX, TEL 2 mg/ml MIC PCG CAM TEL LVFX CPFX L L F L L L L L L L L L C L T G T T T A B T T T D T T E S. pneumoniae PCG, CAM 2 PCG 149 (41.9 ) mg/ml MIC PISP 187 (52.5 ) PRSP 20 (5.6 ) 60 PCG 264 (74.2 ) CAM TEL MIC 2 mg/ml 9 (2.5 ) 3 LVFX, TEL 2 mg/ml PFGE T4 T5, L1 L8 L11, L2 L5 T7 T9, T1 T6 L10, L9 L PCG S. pneumoniae Vol. 19 No
4 24 4. LVFX, TEL 2 mg/ml PFGE Kislak PCG 7) 2 Hansman g PCG MIC 0.6 mg/ml 8) 1977 Appelbaum PCG ST 9) PCG 1981 PCG 10) S. pneumoniae PCG PCG MIC mg/ml S. pneumoniae PCG S. pneumoniae 2 PCG CAM PCG 80 S. pneumoniae (e%ux pomp) mef erm 11, 12) erm S. pneumoniae clindamycin (CLDM) S. pneumoniae PCG 13) S. pneumoniae S. pneumoniae DNA gyrase DNA topoisomerase IV 14) S. pneumoniae TEL, LVFX MFLX, GRNX 1) Niederman, M. S., L. A. Mandell, A. Anzueto, et al Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care Med. 163: ) Bartlett, J. G., S. F. Dowell, L. A. Mandell, et al Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin. Infect. Dis. 31: ) Durand, M. L., S. B. Calderwood, D. J. Weber, et al Acute bacterial meningitis in adults. A review of 493 episodes. N. Engl. J. Med. 328: ) 24 Vol. 19 No
5 Streptococcus pneumoniae Jpn. J. Antibiotics 58: ) Van Bambeke, F., R. R. Reinert, P. C. Appelbaum, et al Multidrug-resistant Streptococcus pneumoniae infections: Current and future therapeutic options. Drugs 67: ) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically Approved standard-seventh edition. M7- A7. Clinical and Laboratory Standards Institute, Wayne, Pa. 7) Kislak, J. W., L. M. Razavi, A. K. Daly, et al Susceptibility of pneumococci to nine antibiotics. Am. J. Med. Sci. 250: ) Hansman, D., M. M. Bullen A resistant pneumococcus. Lancet 2: ) Appelbaum, P. C., A. Bhamjee, J. N. Scragg, et al Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 2(8046): ) Jpn. J. Antibiotics 34: ) Calatayud, L., C. Ardanuy, E. Cercenado, et al Serotypes, clones, and mechanisms of resistance of erythromycin-resistant Streptococcus pneumoniae isolates collected in Spain. Antimicrob. Agents Chemother. 51: ) Klugman, K. P., J. R. Lonks Hidden epidemic of macrolide-resistant pneumococci. Emerg. Infect. Dis. 11: ) Cerdá Zolezzi, P., L. M. Laplana, C. R. Calvo, et al (P. G. Cepero, M. C. Erazo, R. Gómez- Lus, ed.), Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae. Antimicrob. Agents Chemother. 48: ) Adam, H. J., K. N. Schurek, K. A. Nichol, et al Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to Antimicrob. Agents Chemother. 51: Evaluation of Antibacterial Activity of Newer Respiratory Quinolones against Streptococcus pneumoniae Shigeru Fukuzawa, 1) Kazuhiro Tateda, 1, 2) Yoshikazu Ishii, 1, 2) Kyoko Enokizono, 1) Ayumi Hikosaka, 1) Rie Shibuya, 2) Chikako Maehara, 1) Hinako Murakami, 1) Kumiko Yasui, 1) Shigeo Yumoto, 1) Morihiro Iwata, 1) 1, 2) Keizo Yamaguchi 1) Laboratory of Microbiology in Ohmori Hospital, Toho Medical Center 2) Department of Microbiology and Infectious Diseases, Toho University School of Medicine Corresponding author Antimicrobial susceptibility testing of newer quinolones, including developing agents, was performed against 356 strains of Streptococcus pneumoniae isolated in our hospital. Approximately 60 of strains demonstrated less susceptible to penicillin-g. To clarithromycin, 264 strains (74.2 ) were classified to be resistant, while 9 strains (2.5 ) exhibited MIC of 2 mg/ml to telithromycin. MIC 90 (mg/ml) of quinolones were as follows: DX619 (0.031 or less), garenoxacin (0.063), sitafloxacin (0.063), tosfloxacin (0.25), moxifloxacin (0.25), gatifloxacin (0.5), levofloxacin (1), ciprofloxacin (2), pazufloxacin (2). Pulse-field gel electrophoresis analysis using levofloxacin or telithromycin less susceptible strains demonstrated no evidence of wide spreading of antibiotic resistant clone in our hospital. These data suggest e$cacy of newer respiratory quinolones against S. pneumoniae infections, and further support need of continuous surveillance for appearance and spreading of antibiotic resistance organisms. Vol. 19 No
Increasing Genetic Relatedness of Ciprofloxacin-Resistant Streptococcus pneumoniae Isolated in Canada from 1997 to 2005
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 2008, p. 1190 1194 Vol. 52, No. 3 0066-4804/08/$08.00 0 doi:10.1128/aac.01260-07 Copyright 2008, American Society for Microbiology. All Rights Reserved. Increasing
More informationNEW ANTI-INFECTIVE AGENTS IN 2003 : SPECTRUM AND INDICATIONS. 20th Symposium (spring 2003) Thursday May 22nd 2003
NEW ANTI-INFECTIVE AGENTS IN 2003 : SPECTRUM AND INDICATIONS 20th Symposium (spring 2003) Thursday May 22nd 2003 The slides presented at this meeting are available on this site as "Web slide shows" and
More informationMycobacterium fortuitum,
2009 177 Mycobacterium fortuitum 1 1) 2) 3) 1) 1) 4) 4) 5) 2) 1) 1) 2) 3) 4) 5) 21 3 16 21 7 1 Mycobacterium fortuitum 1 39 BHI 2 Ziehl Neelsen M. fortuitum MIC CPFX 0.2 mg/ml, MINO 0.78 mg/ml, CAM 100
More informationGuiding principles* for treating Mycoplasma pneumoniae pneumonia
1 Guiding principles* for treating Mycoplasma pneumoniae pneumonia The Committee of Japanese Society of Mycoplasmology Shigeru Kohno (Chair, Nagasaki University) Tadashi Ishida (Kurashiki Central Hospital)
More informationORIGINAL ARTICLE /j x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.00869.x Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy I. Serrano, M. Ramirez, the Portuguese Surveillance
More information1) 1) 1) 2) 2) (ICU) Key words: (ICU), ( ) 1 30 TEL: FAX: Vol. 17 No
2007 277 1) 1) 1) 2) 2) 3) 4) 5) 6) 1) 2) 3) 4) 5) 6) 18 10 17 19 8 20 16 7 1 (ICU) 20 2x 1.6 2.2 2SD 14 1 4 1 10 7 3 2 9 7.6; 95 2.37 24.62 6 4 5 1 DNA SpeI 9 2 A 7 B 2 A 3 B 1 ICU ICU 7 20 10 5 Key words:
More informationNocardia. Nocardia N. asteroides 12 N. nova 8 N. farcinica 6 16S rdna restriction fragment length polymorphism
2006 81 1) 1), 2) 1) 1) 2) 1) 1) 2) 3) 4) 4) 4) 5) 5) 1), 2) 1) 2) 3) 4) 5) 18 2 8 18 4 19 Nocardia Nocardia 26 26 N. asteroides 12 N. nova 8 N. farcinica 6 16S rdna restriction fragment length polymorphism
More informationMacrolide-resistant phenotypes of invasive Streptococcus pneumoniae isolates in Serbia
Arch. Biol. Sci., Belgrade, 64 (4), 1377-1382, 2012 DOI:10.2298/ABS1204377G Macrolide-resistant phenotypes of invasive Streptococcus pneumoniae isolates in Serbia Ina GajiĆ, NataŠa Opavski, Vera MIJAČ
More informationNTM Mycobacterium avium Mycobacterium intracellulare Complex
2006 67 NTM Mycobacterium aviummycobacterium intracellulare Complex 1) 1) 1) 1) 2) 1) 2) 17 8 29 18 2 9 Mycobacterium avium Mycobacterium intracellulare 6 MIC NTM MIC 1 3 NTM 5 MIC MIC M. avium 1 M. intracellulare
More informationDissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(b) and mef(a) in South Korea
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2003, p. 5787 5791 Vol. 41, No. 12 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.12.5787 5791.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationAntimicrobial susceptibility, carriage, children, day-care centres, orphanages, Streptococcus pneumoniae
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01505.x Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre
More informationACCEPTED ANTIPNEUMOCOCCAL ACTIVITY OF LBM415 COMPARED TO OTHER AGENTS. KLAUDIA KOSOWSKA-SHICK KIM L. CREDITO GLENN A. PANKUCH BONIFACIO DEWASSE
AAC Accepts, published online ahead of print on 20 November 2006 Antimicrob. Agents Chemother. doi:10.1128/aac.01150-06 Copyright 2006, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationDISTRIBUTION OF MACROLIDE-RESISTANT GENES AMONG ISOLATES OF MACROLIDE- RESISTANT STREPTOCOCCUS PYOGENES AND STREPTOCOCCUS PNEUMONIAE IN SERBIA
Arch. Biol. Sci., Belgrade, 66 (1), 93-98, 2014 DOI:10.2298/ABS1401093G DISTRIBUTION OF MACROLIDE-RESISTANT GENES AMONG ISOLATES OF MACROLIDE- RESISTANT STREPTOCOCCUS PYOGENES AND STREPTOCOCCUS PNEUMONIAE
More informationAntimicrobial chemotherapy of Mycoplasma genitaliumpositive. urethritis. Review
For reprint orders, please contact reprints@expert-reviews.com Antimicrobial chemotherapy of Mycoplasma genitaliumpositive non-gonococcal urethritis Expert Rev. Anti Infect. Ther. 10(7), 791 803 (2012)
More informationtelithromycin oral streptococci 140 telithromycin TEL azithromycin AZM clarithromycin CAM roxithromycin RXM levofloxacin LVFX ampicillin ABPC
telithromycin 3 0 3 0 oral streptococci 0 telithromycintelazithromycin AZMclarithromycinCAMroxithromycinRXMlevofloxacinLVFXampicillinABPC erythromycinem TEL EM erm mef 5 Streptococcus mitis MIC90 ml TEL
More informationThe Importance of Appropriate Treatment of Chronic Bronchitis
...CLINICIAN INTERVIEW... The Importance of Appropriate Treatment of Chronic Bronchitis An interview with Antonio Anzueto, MD, Associate Professor of Medicine, University of Texas Health Science Center,
More informationPHENOTYPES AND GENOTYPES OF MACROLIDE-RESISTANT STREPTOCOCCUS PNEUMONIAE IN SERBIA
Arch. Biol. Sci., Belgrade, 66 (1), 99-105, 2014 DOI:10.2298/ABS1401099H PHENOTYPES AND GENOTYPES OF MACROLIDE-RESISTANT STREPTOCOCCUS PNEUMONIAE IN SERBIA MIRJANA HADNAĐEV 1, INA GAJIĆ 2, VERA MIJAC 2,
More informationEscherichia coli b- Extended spectrum b-lactamase (ESBL) 8 (6.5 ), Cephalosporinase (Amp- Amp-C 2. IncF (FIA,FIB) group ESBL 6 Amp-C 4
2011 193 Escherichia coli b- 22 12 20 23 5 30 b- 2006 1 2009 9 744 Escherichia coli b- 4,211 E. coli 123 (2.9) 124 CAZ AZT MIC 2 mg/ml 12 (9.8) 13 Extended spectrum b-lactamase (ESBL) 8 (6.5), Cephalosporinase
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationMulti-drug Resistant Serotype 19A Pneumococci in Toronto
TML Lab Rounds January 17, 2008 Multi-drug Resistant Serotype 19A Pneumococci in Toronto The Role of the Microbiology Lab Susan M. Poutanen, MD, MPH, FRCPC Microbiologist/ID Consultant, TML/MSH Assistant
More informationGAS surveillance. emm12 emm28 emm89 GAS GAS. A GAS Streptococcus pyogenes GAS GAS PSAGN GAS GAS. emm. Vol. 26 No GAS surveillance study group
014 Vol. 6No. 11 A 1 1 GAS surveillance study group A GAS GAS surveillance study group01 GAS 44 PCR 60 GAS emm emm8emm8 GAS emm GAS A GASStreptococcus pyogenes GAS 1 6 1 GAS 1, GAS GAS GAS PSAGN GAS Key
More informationExtremely High Incidence of Macrolide and Trimethoprim- Sulfamethoxazole Resistance among Clinical Isolates of Streptococcus pneumoniae in Taiwan
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1999, p. 897 901 Vol. 37, No. 4 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Extremely High Incidence of Macrolide
More informationAbstract. Introduction
ORIGINAL ARTICLE BACTERIOLOGY In-Vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years R. Krausse
More informationRESEARCH NOTE. 86 Clinical Microbiology and Infection, Volume 12 Number 1, January 2006
86 Clinical Microbiology and Infection, Volume 12 Number 1, January 2006 REFERENCES 1. Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 1998; 26: 1179 1181. 2. Barenfanger J, Drake
More informationUpdate on resistance and epidemiology of CAP pathogens in Asia. Cao Bin, MD
Update on resistance and epidemiology of CAP pathogens in Asia Cao Bin, MD Dept Infectious Diseases and Clinical Microbiology Beijing Chaoyang Hospital, Capital Medical University Outlines Resistance trends
More informationAntibiotic resistance pattern of streptococcus pyogenes isolated from clinical samples with special reference to quinolone resistance
Original Research Article DOI: 10.18231/2394-5478.2017.0022 Antibiotic resistance pattern of streptococcus pyogenes isolated from clinical samples with special reference to quinolone resistance Thipperudraswamy.
More informationACCEPTED. Comparison of disk diffusion and agar dilution methods for erythromycin and
AAC Accepts, published online ahead of print on January 00 Antimicrob. Agents Chemother. doi:./aac.000-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationMethicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods
Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance Report 2008 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services
More informationChanges in the Distribution of Capsular Serotypes of Streptococcus pneumoniae Isolated from Adult Respiratory Specimens in Japan
ORIGINAL ARTICLE Changes in the Distribution of Capsular Serotypes of Streptococcus pneumoniae Isolated from Adult Respiratory Specimens in Japan Hisashi Shoji 1, Masayuki Maeda 2, Tetsuro Shirakura 3,
More informationAffinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED
AAC Accepts, published online ahead of print on February 00 Antimicrob. Agents Chemother. doi:./aac.01-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationShirin Abadi, B.Sc.(Pharm.), ACPR, Pharm.D. Clinical Pharmacy Specialist & Pharmacy Education Coordinator, BC Cancer Agency Clinical Associate
Shirin Abadi, B.Sc.(Pharm.), ACPR, Pharm.D. Clinical Pharmacy Specialist & Pharmacy Education Coordinator, BC Cancer Agency Clinical Associate Professor of Pharmacy & Associate Member of Medicine, UBC
More information(multidrug-resistant Pseudomonas aeruginosa; MDRP)
220 2009 (multidrug-resistant Pseudomonas aeruginosa; MDRP) 21 4 1 21 10 4 amikacin (AMK), imipenem/cilastatin (IPM), ciprofloxacin (CPFX) multidrug-resistant Pseudomonas aeruginosa (MDRP) CHROMagar TM
More informationDifferential impact of macrolide compounds in the selection of macrolide nonsusceptible Streptococcus pneumoniae
Differential impact of macrolide compounds in the selection of macrolide nonsusceptible Streptococcus pneumoniae EDITORIAL JM Blondeau Department of Clinical Microbiology, Royal University Hospital and
More informationManagement of community-acquired lower respiratory tract infections: gemifloxacin, a new economic paradigm
Management of community-acquired lower respiratory tract infections: gemifloxacin, a new economic paradigm DRUG PROFILE Gary Patou, Glenn Tillotson & Joseph Blondeau Author for correspondence University
More informationLaboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator
Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Agenda Discuss 2008 M100- S18
More informationMONTE CARLO SIMULATION & PK-PD TARGET ATTAINMENT ANALYSIS:
MONTE CARLO SIMULATION & PK-PD TARGET ATTAINMENT ANALYSIS: Application to Estimation of MIC Breakpoints Paul G. Ambrose, Pharm.D. Director, Division of Infectious Diseases, Cognigen Corporation; Adjunct
More informationImportance of Atypical Pathogens of Community-Acquired Pneumonia
S35 Importance of Atypical Pathogens of Community-Acquired Pneumonia Joseph F. Plouffe Departments of Internal Medicine and Medical Microbiology and Immunology, Ohio State University College of Medicine,
More informationHigh dose amoxicillin for sinusitis
High dose amoxicillin for sinusitis Amoxil ( amoxicillin ) is a commonly used penicillin antibiotic. It is produced in tablets (500 mg 875 mg), capsules, chewable tablets and oral suspensions. 6-3-2018
More informationMacrolides & Ketolides. Objectives. Protein Synthesis
Macrolides & Ketolides Elizabeth D. Hermsen, Pharm.D. Infectious Diseases Research Fellow University of Minnesota College of Pharmacy bjectives Participant should be able to explain macrolide/ketolide
More informationAcute Bacterial Meningitis in Infants and Children Epidemiology and Management
REVIEW ARTICLE Pediatr Drugs 2011; 13 (6): 385-400 1174-5878/11/0006-0385/$49.95/0 ª 2011 Adis Data Information BV. All rights reserved. Acute Bacterial Meningitis in Infants and Children Epidemiology
More informationSurveillance of invasive pneumococcal infection in Belgium
Surveillance of invasive pneumococcal infection in Belgium National Reference Laboratory Start in 198 Laboratory Microbiology UH Leuven (prof. J. Vandepitte) Capsular type determination Antibiotic susceptibility
More informationKey words: group A, /3-hemolytic streptococci, serotype, pyrogenic exotoxin, antibiotic resistance
Key words: group A, /3-hemolytic streptococci, serotype, pyrogenic exotoxin, antibiotic resistance Table 1 Age of patients and group A streptococcal infections Table 2 Relationship between M-and T-type
More informationMolecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions ( )
DOI 10.1007/s10096-011-1399-3 ARTICLE Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994 2009) J. M. Marimón & M. Alonso & D.
More informationIncrease in numbers of b-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage
Journal of Medical Microbiology (2006), 55, 567 574 DOI 10.1099/jmm.0.46387-0 Increase in numbers of b-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage
More informationKlebsiella pneumoniae 21 PCR
2011 11 TEM-132 ESBL Klebsiella pneumoniae 1) 2) 1) 1) 3) 2) 1) 2) 3) 19 6 27 22 10 20 2003 4 2004 11 95 ceftazidime (CAZ) Klebsiella pneumoniae 21 PCR b- (ESBL) PCR (PFGE) PCR bla TEM-132 PFGE 19 TEM-132
More informationRisk Factors for and Impact of Ambulatory Urinary Tract infections Caused by High Mic- Fluoroquinolone Susceptible E.
University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 1-1-2013 Risk Factors for and Impact of Ambulatory Urinary Tract infections Caused by High Mic- Fluoroquinolone Susceptible
More informationSerotype and genotype replacement among macrolide-resistant invasive. pneumococci in adults. Mechanisms of resistance and association with different
JCM Accepts, published online ahead of print on 10 February 2010 J. Clin. Microbiol. doi:10.1128/jcm.01868-09 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationSteven D. Brown* and Maria M. Traczewski. The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, Oregon 97070
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2010, p. 2063 2069 Vol. 54, No. 5 0066-4804/10/$12.00 doi:10.1128/aac.01569-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Comparative
More informationIntroduction. Journal of Antimicrobial Chemotherapy (2008) 62, Suppl. 2, ii87 ii95 doi: /jac/dkn355
Journal of Antimicrobial Chemotherapy (2008) 62, Suppl. 2, ii87 ii95 doi:10.1093/jac/dkn355 Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory
More informationSerotype Distribution and Antimicrobial Resistance of
BioMed Research International Volume 2016, Article ID 6950482, 7 pages http://dx.doi.org/10.1155/2016/6950482 Research Article Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae
More informationSerotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016
Zhao et al. BMC Infectious Diseases (2017) 17:804 DOI 10.1186/s12879-017-2880-0 RESEARCH ARTICLE Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities
More informationReport on susceptibility of Salmonella serotypes in Belgium Vicky Jasson
CODA-CERVA Report on susceptibility of Salmonella serotypes in Belgium 2014. Vicky Jasson Veterinary and Agrochemical Research Centre 1 Introduction Salmonella is one of the most important bacterial zoonotic
More informationReceived 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005
Journal of Antimicrobial Chemotherapy (2005) 56, 1047 1052 doi:10.1093/jac/dki362 Advance Access publication 20 October 2005 Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity,
More informationMolecular Characterization of Emerging Non-Levofloxacin-Susceptible Pneumococci Isolated from Children in South Africa
JOURNAL OF CLINICAL MICROBIOLOGY, May 2009, p. 1319 1324 Vol. 47, No. 5 0095-1137/09/$08.00 0 doi:10.1128/jcm.02280-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Molecular
More informationInvasive Bacterial Disease
Invasive Bacterial Disease All Streptococcus pneumoniae Electronic Disease Surveillance System Division of Surveillance and Disease Control Infectious Disease Epidemiology Program : 304-558-5358 or 800-423-1271
More informationHUSRES Annual Report 2009 Martti Vaara
HUSRES Annual Report 2009 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara, 2/2010 1 The basis of this HUSRES 2009 report is the HUSLAB/Whonet database 2009, which contains susceptibility data
More information97 80 Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis
4 4 9 6 6 6 7 6 66 4 99.9.7 8. 7..8.4..7.9.. 4. 7.4 8.7 99 97 8 Streptococcus pneumoniae, Haemophilus influenzae, oraxella catarrhalis 4 4 64 7 9 7 89. RT PCR 4. 6 46. Key words: RT PCR I 6 6 46 64. 8.
More informationMolecular Epidemiology of Penicillin-Susceptible, Multidrug- Resistant Serotype 6B Pneumococci Isolated from Children in Greece
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2001, p. 581 585 Vol. 39, No. 2 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.2.581 585.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Molecular
More informationReceived 20 November 2013; returned 19 March 2014; revised 10 April 2014; accepted 19 May 2014
J Antimicrob Chemother 2014; 69: 2835 2840 doi:10.1093/jac/dku207 Advance Access publication 11 June 2014 Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract
More informationHigh-Dose Levofloxacin for the Treatment of Community-Acquired Pneumonia
High-Dose Levofloxacin for the Treatment of Community-Acquired Pneumonia Review Andrew F. Shorr, MD, MPH, FCCP Department of Medicine Pulmonary and Critical Care Medicine, Washington Hospital Center, Washington,
More informationASHP Therapeutic Position Statement on Strategies for Identifying and Preventing Pneumococcal Resistance
678 ASHP Therapeutic Position Statements ASHP Therapeutic Position Statement on Strategies for Identifying and Preventing Pneumococcal Resistance Position The American Society of Health-System Pharmacists
More informationCommunity-acquired pneumonia in adults
Prim Care Clin Office Pract 30 (2003) 155 171 Community-acquired pneumonia in adults Julio A. Ramirez, MD a,b, * a Department of Medicine, University of Louisville School of Medicine, 512 S. Hancock Street,
More informationPolyclonal Population Structure of Streptococcus pneumoniae Isolates in Spain Carrying mef and mef plus erm(b)
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 2008, p. 1964 1969 Vol. 52, No. 6 0066-4804/08/$08.00 0 doi:10.1128/aac.01487-07 Copyright 2008, American Society for Microbiology. All Rights Reserved. Polyclonal
More informationGarenoxacin Treatment of Experimental Endocarditis Caused by Viridans Group Streptococci
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2006, p. 1263 1267 Vol. 50, No. 4 0066-4804/06/$08.00 0 doi:10.1128/aac.50.4.1263 1267.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved.
More informationReceived 16 September 1999/Returned for modification 24 December 1999/Accepted 31 January 2000
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2000, p. 1575 1580 Vol. 38, No. 4 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. A Novel Multiresistant Streptococcus
More informationCharacterization of Mucoid and Non-Mucoid Streptococcus pneumoniae Isolated From Outpatients
Original Article Clinical Microbiology Ann Lab Med 2015;35:410-415 http://dx.doi.org/10.3343/alm.2015.35.4.410 ISSN 2234-3806 eissn 2234-3814 Characterization of Mucoid and Non-Mucoid Streptococcus pneumoniae
More informationMolecular epidemiology and drug resistance mechanism of Salmonella species especially in S. Typhi strains isolated in Bangladesh
Molecular epidemiology and drug resistance mechanism of Salmonella species especially in S. Typhi strains isolated in Bangladesh Dr. Kaisar Ali Talukder Senior Scientist Icddr,b This presentation will
More informationIn vitro and Intracellular Activities of Peptide Deformylase. Inhibitor GSK against Legionella pneumophila Isolates
AAC Accepts, published online ahead of print on 27 October 2014 Antimicrob. Agents Chemother. doi:10.1128/aac.04006-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 In vitro
More informationIncidence per 100,000
Streptococcus pneumoniae Surveillance Report 2005 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services Updated: March 2007 Background
More informationGlobal challenge of antibiotic-resistant Mycoplasma genitalium. by author. Sabine Pereyre
Global challenge of antibiotic-resistant Mycoplasma genitalium Sabine Pereyre USC EA 3671 Mycoplasmal and chlamydial infections in humans INRA - University of Bordeaux -Bordeaux University Hospital National
More informationIn Vitro Susceptibilities of Aerobic and Facultative Non-Spore- Forming Gram-Positive Bacilli to HMR 3647 (RU 66647) and 14 Other Antimicrobials
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 1998, p. 1028 1033 Vol. 42, No. 5 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology In Vitro Susceptibilities of Aerobic and Facultative
More informationSitafloxacin activity against Helicobacter pylori including isolates with gyra. Key words: Helicobacter pylori, sitafloxacin, antimicrobial activity,
AAC Accepts, published online ahead of print on 20 April 2009 Antimicrob. Agents Chemother. doi:10.1128/aac.01552-08 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationWORKSHOP. The Multiple Facets of CAP. Community acquired pneumonia (CAP) continues. Jennifer s Situation
Practical Pointers pointers For for Your your Practice practice The Multiple Facets of CAP Dr. George Fox, MD, MSc, FRCPC, FCCP Community acquired pneumonia (CAP) continues to be a significant health burden
More informationMacrolide-Resistant Pneumococcal Endocarditis and Epidural Abscess that Develop during Erythromycin Therapy
MAJOR ARTICLE Macrolide-Resistant Pneumococcal Endocarditis and Epidural Abscess that Develop during Erythromycin Therapy Jay C. Butler, 1 Jeffrey L. Lennox, 2,3 Linda K. McDougal, 4 Joyce A. Sutcliffe,
More informationPrevalence of carriage of antimicrobial resistant strains of Streptococcus pneumoniae in primary school children in Hong Kong
Epidemiol. Infect. (2001), 127, 49 55. 2001 Cambridge University Press DOI: 10.1017 S0950268801005647 Printed in the United Kingdom Prevalence of carriage of antimicrobial resistant strains of Streptococcus
More informationAcute Bacterial Sinusitis: The latest treatment recommendations. Objectives Having completed the learning activities, the participant will be able to:
Acute Bacterial Sinusitis: The latest treatment recommendations Presented by: Monica Tombasco, MS, MSNA, FNP-BC, CRNA Senior Lecturer Fitzgerald Health Education Associates, Inc., North Andover, MA Emergency
More informationMolecular Characterization of Penicillin-Resistant Streptococcus pneumoniae Isolates from Bulgaria
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1999, p. 638 648 Vol. 37, No. 3 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Molecular Characterization of Penicillin-Resistant
More informationOUTLINE Laboratory Detection and Reporting of Streptococcus agalactiae
OUTLINE Laboratory Detection and Reporting of Streptococcus agalactiae I. Importance of prenatal screening strategies II. Past approaches Erik Munson Clinical Microbiology Wheaton Franciscan Laboratory
More informationDiagnosis of Pneumococcal Disease
Diagnosis of Pneumococcal Disease Limitations of Surveillance for Invasive Disease David Murdoch University of Otago, Christchurch New Zealand Key Points We are still reliant on culture-based methods for
More informationDetection of the Efflux-Mediated Erythromycin Resistance Transposon in Streptococcus pneumoniae
Original Article Clinical Microbiology Ann Lab Med 2015;35:57-61 http://dx.doi.org/10.3343/alm.2015.35.1.57 ISSN 2234-3806 eissn 2234-3814 Detection of the Efflux-Mediated Erythromycin Resistance Transposon
More informationLaboratory Detection and Reporting of Streptococcus agalactiae
Laboratory Detection and Reporting of Streptococcus agalactiae Erik Munson Clinical Microbiology Wheaton Franciscan Laboratory Milwaukee, Wisconsin The presenter states no conflict of interest and has
More informationQ-FEVER Q FEVER. CPMP/4048/01, rev. 3 1/7 EMEA 2002
Q FEVER CPMP/4048/01, rev. 3 1/7 General points on treatment Q fever is a zoonosis caused by Coxiella burnetii, an obligate intracellular gram-negative bacterium with high infectivity but with relatively
More informationWorld Health Organization Department of Communicable Disease Surveillance and Response
WHO/CDS/CSR/DRS/2001.6 Resistant pneumococcal infections Stephanie J. Schrag, Bernard Beall and Scott Dowell World Health Organization Department of Communicable Disease Surveillance and Response This
More informationNewer fluoroquinolones in the treatment of acute exacerbations of COPD
REVIEW Newer fluoroquinolones in the treatment of acute exacerbations of COPD Amit Patel Robert Wilson Royal Brompton Hospital, London UK Abstract: Acute exacerbations of COPD are a major cause of morbidity
More informationTREATMENT OF JAPANESE PATIENTS WITH ENTERIC FEVER USING AZITHROMYCIN AND MIC LEVELS FOR CAUSATIVE ORGANISMS
TREATMENT OF JAPANESE PATIENTS WITH ENTERIC FEVER USING AZITHROMYCIN AND MIC LEVELS FOR CAUSATIVE ORGANISMS Kenji Ohnishi, Ken-ichiro Kobayashi, Sentaro Iwabuchi and Fukumi Nakamura-Uchiyama Department
More informationState of Hong Kong Children
HK J Paediatr (new series) 2001;6:127-132 State of Hong Children Proceedings of The First Current Topic in Infectious Diseases: Consensus Meeting on Conjugate Vaccines of the Center of Infection, Faculty
More informationDesigning Fluoroquinolone Breakpoints for Streptococcus pneumoniae by Using Genetics instead of Pharmacokinetics-Pharmacodynamics
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 2004, p. 3630 3635 Vol. 48, No. 9 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.9.3630 3635.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationTo develop guidelines for the use of appropriate antibiotics for adult patients with CAP and guidance on IV to PO conversion.
Page 1 of 5 TITLE: COMMUNITY-ACQUIRED PNEUMONIA (CAP) EMPIRIC MANAGEMENT OF ADULT PATIENTS AND IV TO PO CONVERSION GUIDELINES: These guidelines serve to aid clinicians in the diagnostic work-up, assessment
More informationOf 142 cases where sex was known, 56 percent were male; of 127cases where race was known, 90 percent were white, 4 percent were
Group B Streptococcus Surveillance Report 2014 Oregon Active Bacterial Core Surveillance (ABCs) Center for Public Health Practice Updated: November 2015 Background The Active Bacterial Core surveillance
More informationThe Role of Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
...SYMPOSIUM PROCEEDINGS... The Role of Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease Robert E. Hillberg, MD Presentation Summary Chronic obstructive pulmonary disease (COPD)
More informationMANAGEMENT OF COMMUNITY ACQUIRED PNEUMONIA IN THE ASIA PACIFIC REGION
MANAGEMENT OF COMMUNITY ACQUIRED PNEUMONIA IN THE ASIA PACIFIC REGION Chong-Kin LIAM Department of Medicine Faculty of Medicine University of Malaya Kuala Lumpur liamck@ummc.edu.my COMMUNITY ACQUIRED PNEUMONIA
More informationTrends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae
International Journal of Antimicrobial Agents 31S (2008) S35 S39 Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae T. Matsumoto Department of Urology, School
More informationINVASIVE PNEUMOCOCCAL DISEASE IN NEW ZEALAND, Helen Heffernan. Julie Morgan. Rosemary Woodhouse. Diana Martin
INVASIVE PNEUMOCOCCAL DISEASE IN NEW ZEALAND, 2009 Helen Heffernan Julie Morgan Rosemary Woodhouse Diana Martin Health Group Institute of Environmental Science and Research Ltd (ESR) Kenepuru Science Centre
More informationBenefits of the pneumococcal immunisation programme in children in the United Kingdom
Benefits of the pneumococcal immunisation programme in children in the United Kingdom 2006-2014 Professor Mary P E Slack mpeslack@gmail.com March 2015 Disclosure of interest The presenter has received
More informationTELITHROMYCIN (KETEK ) A NEW ANTIMICROBIAL AGENT
Volume 19, Issue 12 September 2004 TELITHROMYCIN (KETEK ) A NEW ANTIMICROBIAL AGENT Christopher Cha, Pharm.D. Candidate Introduction Infections that invade the lower respiratory tract, such as community-acquired
More informationSINCE the first descriptions two decades ago of
474 THE NEW ENGLAND JOURNAL OF MEDICINE Aug. 24, 1995 RESISTANCE TO PENICILLIN AND CEPHALOSPORIN AND MORTALITY FROM SEVERE PNEUMOCOCCAL PNEUMONIA IN BARCELONA, SPAIN ROMAN PALLARES, M.D., JOSEFINA LIÑARES,
More informationClinical efficacy and tolerability of grepafloxacin in lower respiratory tract infection
Clinical efficacy and tolerability of grepafloxacin in lower respiratory tract infection Sanford Chodosh Boston Veterans Administration Outpatient Clinic, Boston, Massachusetts, USA Studies in community-acquired
More informationInvasive Pneumococcal Disease in Kanti Children s Hospital, Nepal, as Observed by the South Asian Pneumococcal Alliance Network
SUPPLEMENT ARTICLE Invasive Pneumococcal Disease in Kanti Children s Hospital, Nepal, as Observed by the South Asian Pneumococcal Alliance Network A. S. Shah, 1 M. Deloria Knoll, 2 P. R. Sharma, 1 J. C.
More informationMANAGEMENT of BACTERIAL RHINOSINUSITIS
MANAGEMENT of BACTERIAL RHINOSINUSITIS Jennifer Le, PharmD Assistant Professor of Pharmacy Practice, College of Pharmacy, Western University of Health Sciences Martin S. Lipsky, MD Dean and Professor of
More information